Description:

• Advanced Fourth-Generation Fluoroquinolone: Contains 400mg of Moxifloxacin, a highly potent, broad-spectrum fluoroquinolone antibiotic. It exerts rapid bactericidal activity by inhibiting bacterial topoisomerase II (DNA gyrase) and topoisomerase IV enzymes required for bacterial DNA replication and repair.

• Superior Respiratory Tract Coverage: Specially engineered with enhanced activity against Gram-positive pathogens and atypical bacteria, making it an excellent first-line choice for community-acquired pneumonia (CAP), acute worsening of chronic bronchitis, and severe bacterial sinusitis.

• Combats Complex Soft Tissue Infections: Highly effective in treating complicated skin and skin structure infections (SSSI), providing strong systemic defense against stubborn bacterial invasions.

• Effective Against Intra-Abdominal Infections: Frequently utilized in clinical settings to manage complicated intra-abdominal infections due to its comprehensive coverage against both aerobic and anaerobic bacteria.

• 5-Tablet Once-Daily Treatment Pack: Supplied in a box containing 5 high-strength tablets, perfectly designed for a convenient, short-course once-daily adult regimen to maximize patient compliance.